Dipeptidyl‐Peptidase‐4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low‐Density Lipoprotein (LDL) Receptor‐Deficient Mice

BACKGROUND: The results of recent studies suggest that dipeptidyl‐peptidase‐4 inhibitors have antiatherogenic effects. However, whether or not dipeptidyl‐peptidase‐4 inhibitors could suppress arterial inflammation and intimal hyperplasia after injury remains undetermined. The present study aims to c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Heart Assoc
Autores principales: Akita, Koji, Isoda, Kikuo, Shimada, Kazunori, Daida, Hiroyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4392431/
https://ncbi.nlm.nih.gov/pubmed/25770025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001469
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares